RADIANCE MEDICAL SYSTEMS INC /DE/

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

8.01

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

8.01,9.01

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

1.01,1.03,2.03,2.04,3.01,9.01

8.01,9.01

1.01

5.02

5.02

1.01

5.07

1.01,9.01

Specialized Disclosure Report

General form for quarterly reports under Section 13 or 15(d)

1.01,2.02,2.03,8.01,9.01

3.01

Definitive Proxy Statement

5.02

8.01

5.02,5.03,9.01

8.01

Annual report pursuant to Section 13 or 15(d)

1.01,2.03,3.02,5.03,8.01,9.01

2.02

8.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Specialized Disclosure Report

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Specialized Disclosure Report

Post-effective amendment to an automatic shelf registration statement

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Required Information in Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Specialized Disclosure Report

Correspondence with the SEC

Letter from the SEC

No description available

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Specialized Disclosure Report

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Correspondence with the SEC

Correspondence with the SEC

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Lemaitre Dan

Lemaitre Dan

Brady Timothy Nicholas

Onopchenko John

Pinto Cynthia Buch

Pinto Cynthia Buch

Pinto Cynthia Buch

Thompson Matthew

Wilder Thomas

WALLER GREGORY D

Brady Timothy Nicholas

Thompson Matthew

Onopchenko John

Fecho Jeff

Pinto Cynthia Buch

Pinto Cynthia Buch

Brady Timothy Nicholas

MOTT RICHARD W